Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Join | Sign in
Home>News>This Article
  News
Return

Aratana Therapeutics Announces Conditional Approval of AT-005

Published: Friday, January 31, 2014
Last Updated: Friday, January 31, 2014
Bookmark and Share
AT-005 marks Aratana's first commercial opportunity in T-cell canine lymphoma.


Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
A New Path Towards a Universal Flu Vaccine
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
$1.35 Million Grant to Better Predict Flu Outbreaks
An international research team will receive $1.35 million from the Human Frontier Science Program Organization to better understand how the influenza virus passes from birds to humans.
Too Exhausted to Fight – and to do Harm
An ‘exhausted’ army of immune cells may not be able to fight off infection, but if its soldiers fight too hard they risk damaging the very body they are meant to be protecting, suggests new research from the University of Cambridge.
Researchers Develop a New Means of Killing Harmful Bacteria
Engineered particles are capable of producing toxins that are deadly to targeted bacteria.
Iron: A Biological Element?
Study shows findings which have meaning for fields as diverse as mining and the search for life in space.
Team Led by TSRI Scientists Shows AIDS Vaccine Candidate Successfully ‘Primes’ Immune System
New research shows that an experimental vaccine candidate can stimulate immune activity necessary to prevent HIV infection.
New Tool Identifies Novel Compound Targeting Causes of Type 2 Diabetes
Study identifies small-molecule compound that protects cells against ER stress.
New Immunoregulation and Biomarker
Clinicians at LMU have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases.
Seashells to Deliver New Drugs and Vaccines
Australian scientists have developed a protective seashell-inspired capsule to preserve the active biological ingredients needed to create new drugs.
HIV Paradox
Investigators from Harvard Medical School, Massachusetts General Hospital, and the Ragon Institute of MGH, MIT and Harvard have added another piece to the puzzle of how a small group of individuals known as elite controllers are able to control HIV infection without drug treatment.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters